Vaccine Advances Target Cancer With Personalized Shots
Custom mRNA vaccines tailored to individual tumors are showing promise in trials.
Personalized cancer vaccines that train the immune system to attack a patient's specific tumor are yielding encouraging trial results.
The approach, built on mRNA technology, could complement surgery and chemotherapy to prevent recurrence.
Researchers caution that results are early and manufacturing is complex.
Still, the field represents one of medicine's most hopeful frontiers.
Related Stories
Breakthrough Obesity Pill Shows Injection-Level Results
A once-daily oral drug matched popular injectables in trials, potentially widening access to effective weight-loss treatment.
July 8, 2026
The Longevity Revolution: Science Targets Aging Itself
Researchers are shifting focus from treating diseases to slowing the biology of aging.
July 7, 2026
New study links daily movement to sharper long-term brain health
Researchers found that even modest daily activity is associated with better cognitive outcomes as people age.
July 7, 2026